(Neo:ABXX.NE),(OTC US:ABXXF),(Other OTC:ABXXF), TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company“), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore“), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer of the SmarterMarkets(TM) Podcast, […]

(NASDAQ:ITRM), –-Commercially Launched ORLYNVAH(TM) in the United States in August 2025– –Extended Cash Runway into Q2 2026– –Company to host conference call today at 8:30amET– DUBLIN, Ireland and CHICAGO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company or Iterum), a company focused on delivering next generation oral and IV antibiotics

(NASDAQ:MRKR), APOLLO study showed encouraging overall responses and favorable safety profile in relapsed/refractory B-cell lymphoma MT-601 demonstrated 66% objective response rate with 50% complete response in relapsed Non-Hodgkin lymphoma (NHL) patients in the ongoing APOLLO study First patient treated in Off-the-Shelf program (RAPID study) investigating MAR-T cells in patients with Acute Myeloid Leukemia (AML) or

Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy withKeytruda® (pembrolizumab) as a first-line therapy for advanced and metastatic Merkel cell carcinoma (MCC) is underway, conducted under Special Protocol Assessment (SPA) agreement with the U.S. Food and Drug Administration (FDA) Company's DeltaOpioid Receptor (DOR) technology selected for an oral presentation, along with 2 poster

(NasdaqGM:CSTL), FRIENDSWOOD, Texas, Nov. 14, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating the clinical value of its DecisionDx-Melanoma test in improving sentinel lymph node (SLN) biopsy (SLNB) decision making and enhancing recurrence risk prediction in patients with

DURHAM, N.C., Nov. 14, 2025 (GLOBE NEWSWIRE) — Phononic, a global leader in solid state cooling technology, reveals the cooling solution for AI data centers that unthrottles AI performance while simultaneously delivering attractive returns on infrastructure investment. Today's AI workloads exhibit unprecedented variability, driving throttling that can erode bandwidth, and ultimately compute performance, by as

Delivers USD 1.2 million in contribution profit and 14%YoY EBITDA improvement in Q2 FY25-26. Zoomcar Holdings Inc. (OTCQB: ZCAR), India's leading peer-to-peer car-sharing marketplace, announced results for the quarter ended September 30, 2025 (Q2 FY25-26), marking its eighth consecutive quarter of positive contribution profit and sustained progress toward full profitability. Zoomcar reported a contribution profit

TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending November 30, 2025, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on November 28, 2025 to

(NasdaqGM:ALISU),(NasdaqGM:ALIS),(NasdaqGM:ALISR), NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — Calisa Acquisition Corp (NASDAQ: ALISU) (the “Company”) announced today that, commencing on or about November 19, 2025, holders of its units sold in the Company's initial public offering may elect to separately trade the Company's ordinary shares and rights included in the units. The ordinary shares

(Other OTC:OTCM),(OTC US:OTCM),(TSX:FEC),(Other OTC:FECCF), NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Frontera Energy Corporation (TSX: FEC; OTCQX: FECCF), a Canadian public company involved in the exploration, development, production, transportation, storage and sale of oil and